Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Andrew T Baker"'
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
The Notch pathway is a well-established mediator of cell-cell communication that plays a critical role in stem cell survival, self-renewal, cell fate decisions, tumorigenesis, invasion, metastasis, and drug resistance in a variety of cancers. An inte
Externí odkaz:
https://doaj.org/article/a5b4466b381e4362a2ce1d5097a5af17
Autor:
Louise R Manfredi, Andrew T Baker, Damian O Elias, John F Dammann, Mark C Zielinski, Vicky S Polashock, Sliman J Bensmaia
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31203 (2012)
Because tactile perception relies on the response of large populations of receptors distributed across the skin, we seek to characterize how a mechanical deformation of the skin at one location affects the skin at another. To this end, we introduce a
Externí odkaz:
https://doaj.org/article/b9603ff0e96d438394ae088f94a0d585
Autor:
Clodia Osipo, Lucio Miele, Alexandra Filipovic, Andrew Green, Emad Rakha, Michelle Fernandez, Daniel S. Peiffer, Patricia Simms, Andrew T. Baker, Debra Wyatt, Deep Shah
Primer Sequences for RT-PCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27fba469c005c9aedec57ed6098205a2
https://doi.org/10.1158/1078-0432.22464420.v1
https://doi.org/10.1158/1078-0432.22464420.v1
Autor:
Clodia Osipo, Lucio Miele, Alexandra Filipovic, Andrew Green, Emad Rakha, Michelle Fernandez, Daniel S. Peiffer, Patricia Simms, Andrew T. Baker, Debra Wyatt, Deep Shah
Expression of CD44 and CD24 in response to lapatinib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a7607dae3bc2af828914384d9047bd
https://doi.org/10.1158/1078-0432.22464423
https://doi.org/10.1158/1078-0432.22464423
Autor:
Clodia Osipo, Lucio Miele, Alexandra Filipovic, Andrew Green, Emad Rakha, Michelle Fernandez, Daniel S. Peiffer, Patricia Simms, Andrew T. Baker, Debra Wyatt, Deep Shah
Purpose: HER2-positive breast cancer is driven by cells possessing stem-like properties of self-renewal and differentiation, referred to as cancer stem cells (CSC). CSCs are implicated in radiotherapy, chemotherapy resistance, and tumor recurrence. N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5549960ed766a1fb0fcd7a1ffb2741c3
https://doi.org/10.1158/1078-0432.c.6525714.v1
https://doi.org/10.1158/1078-0432.c.6525714.v1
Publikováno v:
Cancers, Vol 11, Iss 11, p 1631 (2019)
Ovarian cancer cells evade the immune system as well as chemotherapeutic and/or biologic treatments through inherent or acquired mechanisms of survival and drug resistance. Depending on the cell type and the stimuli, this threshold can range from ext
Externí odkaz:
https://doaj.org/article/761abbd1077e4833a526fc7c1c400376
Autor:
Nick Dirckx, Allen S. Anderson, Gregory A. Ewald, Michael M. Givertz, Shelley A. Hall, Sean Pinney, D. Rinde-Hoffman, Claudius Mahr, Jennifer A Cowger, Daniel Jacoby, Jerry D. Estep, Andrew T Baker, Leway Chen, Andreas Brieke
Publikováno v:
ASAIO Journal. 68:374-383
Targeted blood pressure (BP) control is a goal of left ventricular assist device medical management, but the interpretation of values obtained from noninvasive instruments is challenging. In the MOMENTUM 3 Continued Access Protocol, paired BP values
Autor:
Deep Shah, Clodia Osipo, Patricia E. Simms, Emad A. Rakha, Aleksandra Filipovic, Lucio Miele, Debra Wyatt, Andrew T. Baker, Daniel S. Peiffer, Michelle L. Fernandez, Andrew R. Green
Publikováno v:
Clinical Cancer Research. 24:4566-4578
Purpose: HER2-positive breast cancer is driven by cells possessing stem-like properties of self-renewal and differentiation, referred to as cancer stem cells (CSC). CSCs are implicated in radiotherapy, chemotherapy resistance, and tumor recurrence. N
Publikováno v:
Cancers, Vol 11, Iss 11, p 1631 (2019)
Cancers
Cancers
Ovarian cancer cells evade the immune system as well as chemotherapeutic and/or biologic treatments through inherent or acquired mechanisms of survival and drug resistance. Depending on the cell type and the stimuli, this threshold can range from ext
Autor:
Andrew T. Baker, Aleksandra Filipovic, Maurizio Bocchetta, Kathy S. Albain, Andrew R. Green, Daniel S. Peiffer, Jun Li, Clodia Osipo, Lucio Miele, Suzanne A. W. Fuqua, Debra Wyatt
Publikováno v:
Oncogene
Trastuzumab targets the HER2 receptor on breast cancer cells to attenuate HER2-driven tumor growth. However, resistance to trastuzumab-based therapy remains a major clinical problem for women with HER2+ breast cancer. Breast cancer stem cells (BCSCs)